About our company
GREINER BIO-ONE IS MAKING A DIFFERENCE
Our performance in 2023: Challenging market situation affects results
As the COVID-19 pandemic subsided and disrupted supply chains were restored, customers across the industry built up massive inventories, which in turn led to a decline in current demand. The business unit is also challenged by high inflation and interest rates, which have significantly driven up production costs at its main facilities.
Incoming orders in Preanalytics declined slightly but remained at a high level. In the BioScience unit, Greiner Bio-One continued to feel the effects of the cost-cutting measures taken by many research institutes: projects were postponed and fewer consumables were needed.
āWe want to contribute to remarkable successes in medicine and make a real difference for users and patients.ā
Turnover
| Year | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
| Turnover | 473.0 | 473.0 | 509.0 | 693.0 | 695.0 | 693.0 | 637.0 |
Greiner Bio-One Company Movie
To us, health is the highest personal priority. This inspires our daily mission of serving life sciences and healthcare professionals with advanced and sustainable products and solutions. It is the passion and dedication of our people that make the difference. With a straightforward approach our global team continuously strives for excellence and closely collaborates with our customers. That is where our product solutions for preanalytics, research and biotechnology come in. Weāre here for you worldwide, right where you need us.
Greiner Annual and Sustainability Report
Core Business
Greiner Bio-One specialises in the development, production and distribution of high-quality plastic laboratory products. The company is a technology partner for hospitals, laboratories, universities, research institutes, and the diagnostic, pharmaceutical and biotechnology industries.
The Preanalytics business division, with headquarters in KremsmĆ¼nster (Austria), develops and produces innovative collection systems for human and veterinary blood and urine samples, with the aim of making day-to-day, routine tasks in hospitals, laboratories and doctorsā practices easier and safer. This division also covers customised software solutions (Tracie Healthcare Solutions) which ensure greater efficiency and patient safety in the preanalytical process.
Greiner Bio-Oneās BioScience division, with headquarters in Frickenhausen (Germany), is one of the leading providers of specialist products for the cultivation and analysis of cell and tissue cultures. Based on decades of experience in the cryopreservation of samples, Greiner Bio-One also offers solutions for automated storage systems in biobanks. In addition, the division also develops and produces microplates for high-throughput screening, which ensure the quickest and most efficient testing of substances and materials in both industry and research.
As an Original Equipment Manufacturer (OEM), Greiner Bio-One is also a solid partner for industry clients working in pharmaceuticals, biotechnology, diagnostics and medical technology and offers customised design development and production processes.
āOur central objective is to ensure that: We embody our values and our conduct is legally and ethically impeccable! The Management Board will do everything in its power to ensure that the standards established in this code of conduct are permanently implemented and respected in all parts of the Group. ā
The Greiner Group, with almost 150 years of history, has become a real global player in the past few years. With more than 125 sites across the globe, we are close to our customers and can flexibly respond to their needs. However, such a complex organisation also presents challenges.
We would like this code of conduct to serve as a basis on which our companyās positive development can continue in the long term. The code is rooted in the Greiner philosophy, which focuses on the global orientation of the Group, its attractiveness as an employer and service provider, and excellent conduct. We have set the rules of conduct derived from these principles in stone in the code of conduct and made them available to all employees, customers, and business partners. It should help us to guarantee the integrity of our conduct in the long term.
Our central objective is to ensure that: We embody our values and our conduct is legally and ethically impeccable!
The Management Board will do everything in its power to ensure that the standards established in this code of conduct are permanently implemented and respected in all parts of the Group. It is our deliberate wish and declared aim to set a good example. We invite all employees to join us on this path.
Research and development have always been among the drivers for growth in any economic system. Medical technology and biotechnology in particular have, over the last few decades, experienced steady upwards growth.
The commercial success of Greiner Bio-One is based upon the consistent advancement of modern technologies and techniques. A significant proportion of the company's turnover is invested in R&D. At the company's facilities in Austria and Germany, teams of product specialists from all manner of different disciplines are working on designing and implementing innovative solutions.
At Greiner Bio-One, specialists in microbiology, chemistry, physics and plastics engineering work on the development of new processes and products. Greiner Bio-One has its own state-of-the-art research centre in KremsmĆ¼nster (Upper Austria) for the development of molecular biology analysis methods based on DNA arrays. Clinical studies are prepared and performance assessment testing carried out in the company's own clinical laboratory.
Extensive networks incorporating selected partner firms, public institutions and organisations mean that Greiner Bio-One is always able to identify relevant issues, the latest developments and emerging trends early and then translate them into product solutions.
As a supplier of high-quality products for medical research and manufacturers of diagnostic agents, we bear responsibility for countless analyses that are carried out worldwide in research organisations, laboratories and hospitals using our products. We regard our customers' confidence for 50 years as testimony to the superlative quality standard we offer and also as an obligation to continue improving the quality of our products even further.
Quality comes first at Greiner Bio-One. Our products are expected to deliver the highest quality. All production sites are ISO 9001 and ISO 13485 certified. We also meet countless national and international quality requirements. By using state-of-the-art production technologies, manufacturing under special environmental conditions and deploying highly skilled staff, we are able to continuously improve the quality of our products and processes.
Greiner Bio-One applies a carefully developed quality assurance system to fully meet all customer requirements. Our optimised processes encompass the entire supply chain, starting from careful selection of suppliers through development and product realisation to the controlled sale of our products. All products are labelled in accordance with the applicable statutory provisions and can be traced back to the components and suppliers used.
The products and process are regularly audited by national and international authorities and authorisation bodies. Each stage of production is constantly and systematically monitored by our staff, to ensure excellent product quality, determine where improvements can be made and optimise this potential. We strive to optimise all processes to the benefit of our customers. Risk management is a core element of our approach to quality.
The best quality management system is only as good as the people who apply it. Special focus is placed on the training, qualification and continued development of the entire Greiner Bio-One team. We regularly hold quality and product training sessions for our staff, at which they are shown how all Greiner Bio-One products are used, and the resulting quality requirements. Through these measures, we can achieve the highest quality standards for our customers on a day-to-day basis.
